Trexquant Investment’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-71,880
| Closed | -$1.2M | – | 1834 |
|
|
2025
Q1 | $1.2M | Sell |
71,880
-73,233
| -50% | -$1.35M | 0.01% | 1036 |
|
|
2024
Q4 | $2.74M | Sell |
145,113
-63,088
| -30% | -$1.22M | 0.03% | 752 |
|
|
2024
Q3 | $3.91M | Buy |
208,201
+28,165
| +16% | +$540K | 0.05% | 568 |
|
|
2024
Q2 | $3.4M | Sell |
180,036
-204,885
| -53% | -$3.49M | 0.05% | 536 |
|
|
2024
Q1 | $6.25M | Buy |
384,921
+111,521
| +41% | +$1.63M | 0.12% | 234 |
|
|
2023
Q4 | $3.46M | Sell |
273,400
-34,217
| -11% | -$432K | 0.08% | 367 |
|
|
2023
Q3 | $4.19M | Buy |
307,617
+221,636
| +258% | +$3.42M | 0.11% | 272 |
|
|
2023
Q2 | $1.48M | Buy |
85,981
+1,527
| +2% | +$23.7K | 0.04% | 608 |
|
|
2023
Q1 | $1.18M | Buy |
84,454
+26,638
| +46% | +$392K | 0.03% | 664 |
|
|
2022
Q4 | $773K | Buy |
+57,816
| New | +$747K | 0.02% | 748 |
|
|
2022
Q3 | – | Sell |
-17,933
| Closed | -$228K | – | 1792 |
|
|
2022
Q2 | $228K | Buy |
+17,933
| New | +$230K | 0.01% | 1283 |
|
|
2021
Q3 | – | Sell |
-20,826
| Closed | -$474K | – | 1445 |
|
|
2021
Q2 | $474K | Buy |
20,826
+7,181
| +53% | +$149K | 0.04% | 516 |
|
|
2021
Q1 | $251K | Buy |
+13,645
| New | +$224K | 0.02% | 848 |
|
|
2020
Q3 | – | Sell |
-21,058
| Closed | -$167K | – | 1500 |
|
|
2020
Q2 | $167K | Buy |
+21,058
| New | +$174K | 0.01% | 1072 |
|
|
2020
Q1 | – | Sell |
-43,898
| Closed | -$552K | – | 1381 |
|
|
2019
Q4 | $552K | Sell |
43,898
-5,965
| -12% | -$64.2K | 0.03% | 526 |
|
|
2019
Q3 | $445K | Buy |
49,863
+6,440
| +15% | +$56.3K | 0.04% | 483 |
|
|
2019
Q2 | $371K | Sell |
43,423
-41,676
| -49% | -$329K | 0.03% | 547 |
|
|
2019
Q1 | $646K | Buy |
85,099
+17,645
| +26% | +$142K | 0.05% | 515 |
|
|
2018
Q4 | $558K | Buy |
+67,454
| New | +$645K | 0.03% | 581 |
|
|
2018
Q3 | – | Sell |
-22,625
| Closed | -$221K | – | 1166 |
|
|
2018
Q2 | $221K | Buy |
+22,625
| New | +$222K | 0.02% | 766 |
|
|
2017
Q2 | – | Sell |
-34,767
| Closed | -$250K | – | 1127 |
|
|
2017
Q1 | $250K | Buy |
+34,767
| New | +$252K | 0.03% | 856 |
|
|
2016
Q3 | – | Sell |
-58,464
| Closed | -$342K | – | 977 |
|
|
2016
Q2 | $342K | Buy |
+58,464
| New | +$387K | 0.04% | 621 |
|
|
2015
Q3 | – | Sell |
-181,730
| Closed | -$1.59M | – | 1237 |
|
|
2015
Q2 | $1.59M | Buy |
+181,730
| New | +$1.53M | 0.18% | 171 |
|
Other funds holding SEM
8KM
HRCM
Trexquant Investment's SEM Position: Q2 2025 in Review
Trexquant Investment sold out of Select Medical (SEM) in Q2 2025, closing a stake of 71,880 shares — an estimated $1.2M sold.
Trexquant Investment first reported a position in SEM in Q2 2015 and held it in 23 quarters. The position peaked at $6.25M in Q1 2024. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.
- Trexquant Investment reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
- Trexquant Investment sold 71,880 Select Medical shares in Q2 2025, an estimated $1.2M.
- Trexquant Investment first reported a position in Select Medical in Q2 2015 and held it in 23 quarters.
- Trexquant Investment's Select Medical position peaked at $6.25M in Q1 2024.
- 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.
Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.